153 related articles for article (PubMed ID: 16495812)
21. Monitoring peripheral blood CD4+ adenosine triphosphate activity in a liver transplant cohort: insight into the interplay between hepatitis C virus infection and cellular immunity.
Mendler M; Kwok H; Franco E; Baron P; Weissman J; Ojogho O
Liver Transpl; 2008 Sep; 14(9):1313-22. PubMed ID: 18756485
[TBL] [Abstract][Full Text] [Related]
22. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
Raziorrouh B; Jung MC; Schirren CA; Loehe F; Thiel M; Nitschko H; Diepolder H; Ulsenheimer A; Heeg M; Zachoval R; Gruener NH
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):778-83. PubMed ID: 18617783
[TBL] [Abstract][Full Text] [Related]
23. Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus.
Fiel MI; Agarwal K; Stanca C; Elhajj N; Kontorinis N; Thung SN; Schiano TD
Liver Transpl; 2008 Jun; 14(6):861-71. PubMed ID: 18508382
[TBL] [Abstract][Full Text] [Related]
24. Preserving renal function in liver transplant recipients with rabbit anti-thymocyte globulin and delayed initiation of calcineurin inhibitors.
Bajjoka I; Hsaiky L; Brown K; Abouljoud M
Liver Transpl; 2008 Jan; 14(1):66-72. PubMed ID: 18161842
[TBL] [Abstract][Full Text] [Related]
25. Minimization of immunosuppression with thymoglobuline pre-treatment and HCV recurrence in liver transplantation.
De Ruvo N; Cucchetti A; Lauro A; Masetti M; Di Benedetto F; Cautero N; La Barba G; Dazzi A; Di Francesco F; Molteni G; Romano A; Ramacciato G; Risaliti A; Pinna AD
Clin Transplant; 2005 Apr; 19(2):255-8. PubMed ID: 15740564
[TBL] [Abstract][Full Text] [Related]
26. High dose rabbit antithymocyte globulin induction in living related liver transplantation.
Masetti M; Montalti R; Arpinati M; Di Benedetto F; Miller CM; Zagnoli A; De Ruvo N; Guerrini GP; Romano A; Rondelli D; Chirumbolo G; Rompianesi G; Pinna AD; Gerunda GE
Hepatogastroenterology; 2007; 54(75):884-8. PubMed ID: 17591084
[TBL] [Abstract][Full Text] [Related]
27. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation.
Yilmaz N; Shiffman ML; Stravitz RT; Sterling RK; Luketic VA; Sanyal AJ; Mills AS; Contos MJ; Coterell A; Maluf D; Posner MP; Fisher RA
Liver Transpl; 2007 Jul; 13(7):975-83. PubMed ID: 17600360
[TBL] [Abstract][Full Text] [Related]
28. Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting.
Muzi F; Orlando G; Ielpo B; Anselmo A; Sabato Ceraldi S; de Liguori Carino N; Manzia T; D'Andria D; Tariciotti L; Angelico M; Tisone G
Transplant Proc; 2005 May; 37(4):1705-7. PubMed ID: 15919438
[TBL] [Abstract][Full Text] [Related]
29. Effect of calcineurin inhibitors on survival and histologic disease severity in HCV-infected liver transplant recipients.
Berenguer M; Aguilera V; Prieto M; San Juan F; Rayón JM; Benlloch S; Berenguer J
Liver Transpl; 2006 May; 12(5):762-7. PubMed ID: 16528713
[TBL] [Abstract][Full Text] [Related]
30. Does interferon use prior to liver transplant influence hepatitis C outcomes following transplantation?
Smallwood GA; Devine R; Fasola C; Stieber AC; Heffron TG
Transplantation; 2008 Dec; 86(12):1795-8. PubMed ID: 19104424
[TBL] [Abstract][Full Text] [Related]
31. Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine.
Villamil F; Levy G; Grazi GL; Mies S; Samuel D; Sanjuan F; Rossi M; Lake J; Munn S; Mühlbacher F; Leonardi L; Cillo U
Transplant Proc; 2006 Nov; 38(9):2964-7. PubMed ID: 17112875
[TBL] [Abstract][Full Text] [Related]
32. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
33. Elevated CD4+/CD25+ T-cell frequency and function during hepatitis C virus recurrence after liver transplantation.
Perrella A; Arenga G; Pisaniello D; Rampone B; Di Costanzo GG; Atripaldi L; Esposito C; Di Florio E; Perrella O; Cuomo O
Transplant Proc; 2009 Jun; 41(5):1761-6. PubMed ID: 19545723
[TBL] [Abstract][Full Text] [Related]
34. Elevated interleukin-4 expression in severe recurrent hepatitis C virus after liver transplantation.
Dharancy S; Podevin P; Aoudjehane L; Batteux F; Rosenberg AR; Soubrane O; Calmus Y; Conti F
Transplantation; 2007 Apr; 83(7):906-11. PubMed ID: 17460561
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic management of recurrent hepatitis C after liver transplantation.
Teixeira R; Menezes EG; Schiano TD
Liver Int; 2007 Apr; 27(3):302-12. PubMed ID: 17355450
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C.
Burra P
Semin Liver Dis; 2009 Feb; 29(1):53-65. PubMed ID: 19235659
[TBL] [Abstract][Full Text] [Related]
37. Preliminary results of a "prope" tolerogenic regimen with thymoglobulin pretreatment and hepatitis C virus recurrence in liver transplantation.
De Ruvo N; Cucchetti A; Lauro A; Masetti M; Cautero N; Di Benedetto F; Dazzi A; Del Gaudio M; Ravaioli M; Di Francesco F; Molteni G; Ramacciato G; Risaliti A; Pinna AD
Transplantation; 2005 Jul; 80(1):8-12. PubMed ID: 16003226
[TBL] [Abstract][Full Text] [Related]
38. Influence of steroids on HCV recurrence after liver transplantation: A prospective study.
Vivarelli M; Burra P; La Barba G; Canova D; Senzolo M; Cucchetti A; D'Errico A; Guido M; Merenda R; Neri D; Zanello M; Giannini FM; Grazi GL; Cillo U; Pinna AD
J Hepatol; 2007 Dec; 47(6):793-8. PubMed ID: 17928091
[TBL] [Abstract][Full Text] [Related]
39. Detection of HCV antigens in liver graft: relevance to the management of recurrent post-liver transplant hepatitis C.
Grassi A; Quarneti C; Ravaioli M; Bianchini F; Susca M; D'Errico A; Piscaglia F; Tamè MR; Andreone P; Grazi G; Galli S; Zauli D; Pinna AD; Bianchi FB; Ballardini G
Liver Transpl; 2006 Nov; 12(11):1673-81. PubMed ID: 17031825
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis C virus viral load after conversion from tacrolimus to cyclosporine in liver transplant patients: a pilot study.
Guitard J; Sandres-Sauné K; Kamar N; Ribes D; Faguer S; Esposito L; Lavit M; Muscari F; Péron JM; Lavayssière L; Durand D; Rostaing L
Transplant Proc; 2007 Oct; 39(8):2603-5. PubMed ID: 17954189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
